Company Monitoring Page for Novartis

latest headlines for company on cafepharma

Novartis AG and Amgen Inc. Take Aim at Johnson & Johnson
Motley Fool
Mon, 12/15/14 - 08:50 am
Tags:
Novartis, Amgen, JNJ, Stelara, psoriasis, brodalumab, Cosentyx
Novartis' psoriasis drug tops J&J's Stelara as it speeds toward approval
Fierce Biotech
Fri, 12/12/14 - 08:51 am
Tags:
Novartis, psoriasis, JNJ, Stelara, secukinumab
Tasigna Wins Over Gleevec in Ph+CML Patients
Drug Discovery and Development
Tue, 12/9/14 - 11:42 am
Tags:
Tasigna, Gleevec, chronic myeloid leukemia, Novartis
Novartis lays off 200 primary care reps as it preps for megablockbuster LCZ696 rollout
Fierce Pharma Marketing
Mon, 12/8/14 - 12:30 pm
Tags:
Novartis, layoffs, drug reps
The 7 Most Important Drug-Stock Lessons From This Weekend's Blood Cancer Meeting
TheStreet.com
Mon, 12/8/14 - 10:30 am
Tags:
Agios Pharmaceuticals, Novartis, CAR-T, Celgene, Amgen, Merck, Bristol-Myers Squibb, Seattle Genetics, Sunesis
Novartis copy of Amgen biotech drug shows similar efficacy-study
Yahoo/Reuters
Mon, 12/8/14 - 08:24 am
Tags:
Novartis, Amgen, Neupogen, biosimilars, Sandoz, neutropenia
Using Re-Engineered Immune Cells to Kill Leukemia Induces Lasting Remissions
The Street
Sun, 12/7/14 - 10:15 am
Tags:
leukemia, Novartis, Kite Therapeutics, Celgene, Bluebird Bio
Array Biopharma Regains Rights to Cancer Drug From Novartis
TheStreet.com
Wed, 12/3/14 - 09:16 pm
Tags:
Array Biopharma, Novartis, binimetinib, cancer, GSK
After Initial Testing, Italian Regulator Now Says Novartis Flu Vaccine is Safe
WSJ Pharmalot
Mon, 12/1/14 - 07:32 pm
Tags:
Novartis, vaccines, flu vaccine, Italy, Fluad
Novartis’s Gilenya Fails to Help Hard-to-Treat Form of MS
Bloomberg
Mon, 12/1/14 - 09:59 am
Tags:
Novartis, Gilenya, MS, multiple sclerosis
Italy Suspends Batches of Novartis Flu Vaccine After 3 Deaths
Bloomberg
Sat, 11/29/14 - 12:43 pm
Tags:
Novartis, vaccines, flu vaccines, Italy, Fluad
Novartis says heart-failure drug wins faster review in Europe
Yahoo/Reuters
Sat, 11/29/14 - 10:30 am
Tags:
Novartis, heart failure, Europe, LCZ696
Who are the stars of personalized medicine? Roche, Novartis and J&J
Fierce Pharma Marketing
Wed, 11/26/14 - 11:43 am
Tags:
personalized medicine, Roche, Novartis, JNJ
Priority review period for Novartis cancer drug extended
Seeking Alpha
Tue, 11/25/14 - 09:57 am
Tags:
Novartis, Multiple Myeloma, panobinostat, bortezomib
Novartis Dismisses Employee who Fabricated Data in Research Papers
WSJ Pharmalot
Tue, 11/25/14 - 09:53 am
Tags:
Novartis
GSK shareholders to vote on Novartis deal on Dec. 18
Yahoo/Reuters
Mon, 11/24/14 - 09:39 am
Tags:
GSK, Novartis, cancer, consumer health, vaccines, M&A
Novartis' Enbrel beater bounds toward psoriasis approval ahead of the crowd
Fierce Biotech
Fri, 11/21/14 - 10:30 am
Tags:
Novartis, Enbrel, psoriasis, Cosentyx
Europe gives green light to AbbVie hepatitis C medicine, others
Yahoo/Reuters
Fri, 11/21/14 - 08:11 am
Tags:
Europe, AbbVie, hepatitis C, dasabuvir, Sanofi, eliglustat, Novartis, secukinumab, Merck, Vorapaxar, Boehringer Ingelheim, nintedanib
Pfizer's MenB reach--and lead on Novartis--limited without ACIP nod
Fierce Vaccines
Thu, 11/20/14 - 10:57 am
Tags:
Pfizer, Novartis, FDA, meningitis B, vaccines, Bexsero
How to prep for a 'megablockbuster' launch? Novartis lines up cost-savings data
Fierce Pharma Marketing
Thu, 11/20/14 - 10:51 am
Tags:
Novartis, LCZ696, drug launches

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.